echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The first successful implementation of car-t immunocytotherapy in Anhui Province

    The first successful implementation of car-t immunocytotherapy in Anhui Province

    • Last Update: 2015-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On August 11, Xiaolei, a 6-year-old child with leukemia, received car-t cell immunotherapy in the Department of Hematology, the Second Affiliated Hospital of Anhui Medical University After receiving car-t cell immunotherapy, his condition improved significantly and his face showed a happy smile Since the beginning of June, the Department of Hematology, the Second Affiliated Hospital of Anhui Medical University, has cooperated with the Weiming Institute of bioeconomy, Peking University of Anhui Province to successfully implement car-t cell immunotherapy for the first three leukemia patients, which is the first time in Anhui Province Car-t, or chimeric antigen receptor T cell immunotherapy Its basic principle is to use the patient's autoimmune cells to remove cancer cells, which belongs to cell therapy, rather than using drugs It first extracts T cells from patients' peripheral blood (blood outside the bone marrow), and then carries out gene engineering modification in the laboratory, large-scale amplification and then reinfusion into patients At this time, the recoded T cells can obtain the ability of specific recognition and attack and kill tumor cells, especially for leukemia cells, such as "cell missile", which can accurately "spot" leukemia cells without damaging normal cells Using the power of patients' autoimmune system to resist cancer is a subversive breakthrough in cancer research It is reported that the most mature and effective treatment is B-lymphocytic leukemia and lymphoma Car-t cells for other malignant tumors are under development, with a promising future The technicians used multi parameter flow cytometry to detect and analyze the leukemia cells in the bone marrow of patients before and after treatment The cell culture dish was placed in the incubator for about a week The technicians carried out the cell classification test of bone marrow smear under the microscope Technicians are checking the cell culture bag in the sterile laboratory Through the sterility test, phenotype analysis and function test, the preparation can be infused back to the small patients of the human body and the condition can be significantly relieved Both father and son have a bright and happy smile
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.